Correction to Scalable Ruthenium-Catalyzed Asymmetric Synthesis of

Jan 13, 2016 - An Improved and Enantioselective Preparation of the Telaprevir Bicyclic [3.3.0] Proline Intermediate and Reuse of Unwanted Enantiomer...
0 downloads 0 Views 108KB Size
Addition/Correction pubs.acs.org/OPRD

Correction to Scalable Ruthenium-Catalyzed Asymmetric Synthesis of a Key Intermediate for the β2-Adrenergic Receptor Agonist Masato Komiyama,* Takahiro Itoh, and Takumi Takeyasu Org. Process Res. Dev. 2015, 19, 315−319. DOI: 10.1021/op500338d n page 318, in the procedure for benzyl N-[(2R)-2-[8(benzyloxy)-2-oxo-1,2-dihydroquinolin-5-yl]-2hydroxyethyl]carbamate (2c), the mole of (S,S)-Ms-DENEB (0.0457 kg, 0.0158 mol) was incorrect although the gram is correct. The correct value is 0.0457 kg and 0.0796 mol.

O

Published: January 13, 2016 © 2016 American Chemical Society

325

DOI: 10.1021/acs.oprd.5b00400 Org. Process Res. Dev. 2016, 20, 325−325